Frederick D. Sancilio

Adobe Systems (United States) — United States

Nursing · Health Sciences

9h-index258citations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fatty Acid Research and Health(5), Analytical Chemistry and Chromatography(5), Diet and metabolism studies(3), Microbial Natural Products and Biosynthesis(2), Drug Solubulity and Delivery Systems(2)

Publications25 total

Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress
Journal of Psychoactive Drugs·2026
A Quantitative‐EEG Assessment of Alpha‐1062, a Novel Pro‐Drug of Galantamine for the Treatment of Mild to Moderate Dementia Associated with Alzheimer’s Disease.
Alzheimer s & Dementia·2022
SC411 treatment can enhance survival in a mouse model of sickle cell disease
Prostaglandins Leukotrienes and Essential Fatty Acids·2020· 4 citedOpen Access
Advanced Lipid Technologies® (ALT®): A Proven Formulation Platform to Enhance the Bioavailability of Lipophilic Compounds
Journal of Drug Delivery·2019· 15 citedOpen Access
Triglyceride-Lowering Effect of Omega-3 Fatty Acid Ethyl Esters Using Advanced Lipid Technologiestm (ALT ® ) formulations Under Fasting Conditions
Journal of clinical lipidology·2017
A Novel Omega-3-Acid Ethyl Ester formulation Incorporating Advanced Lipid Technologies (ALTÂ ® ) Improves DHA and EPA bioavailability compared with Lovaza
Journal of clinical lipidology·2017· 1 cited
Minimal Food Effect for Eicosapentaenoic Acid and Docosahexaenoic Acid Bioavailability from Omega-3 Acid Ethyl Esters with an ALT based formulation
Journal of clinical lipidology·2017
Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3–acid ethyl esters with an Advanced Lipid Technologies TM (ALT ® )–based formulation
Journal of clinical lipidology·2017· 25 cited
Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance
Clinical Therapeutics·2017· 12 cited
A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies TM (ALT ® ) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza ®
Clinical Therapeutics·2017· 27 cited
Prevention Is the Cure
2015· 3 cited
A Dietary Supplement with a High Eicosapentaenoic Acid to Docosahexaenoic Acid Ratio Reduces Triglyceride Levels in Mildly Hypertriglyceridemic Subjects
Food and Nutrition Sciences·2013Open Access
Development and Validation of a Single HPLC Method for Analysis of Purines in Fish Oil Supplements
Food and Nutrition Sciences·2013· 7 citedOpen Access
Thermally-Prepared Polymorphic Forms of Cilostazol
Journal of Pharmaceutical Sciences·2002· 35 cited
High-Performance Liquid Chromatographic Analysis of Trimethoprim and Sulfamethoxazole in Dosage Forms
Journal of Pharmaceutical Sciences·1980· 21 cited
ChemInform Abstract: Megalomicins. Part 7. A Structural Revision by Carbon‐l3 Nuclear Magnetic Resonance and X‐Ray Crystallography. Synthesis and Conformational Analysis of 3‐Dimethylamino‐ and 3‐Azido‐D‐ and ‐L‐hexopyranosides, and the Crystal Structure of 4“‐O‐(4‐Iodobenzoyl)megalomicin A.
Chemischer Informationsdienst·1979
The megalomicins. Part 7. A structural revision by carbon-13 nuclear magnetic resonance and X-ray crystallography. Synthesis and conformational analysis of 3-dimethylamino- and 3-azido-<scp>D</scp>- and -<scp>L</scp>-hexopyranosides, and the crystal structure of 4″-O-(4-lodobenzoyl)megalomicin A
Journal of the Chemical Society Perkin Transactions 1·1979· 38 cited
Analysis of Steroid Phosphates by High-Pressure Liquid Chromatography: Betamethasone Sodium Phosphate
Journal of Pharmaceutical Sciences·1978· 15 cited
Gentamicin C-component ratio determination by high-pressure liquid chromatography
Journal of Chromatography A·1978· 43 cited
ChemInform Abstract: MEGALOMICINS. 6. TERTIARY GLYCOSIDIC MACROLIDE ANTIBIOTICS. A STRUCTURAL REVISION BY CARBON‐13 NUCLEAR MAGNETIC RESONANCE AND X‐RAY CRYSTALLOGRAPHY
Chemischer Informationsdienst·1978· 5 cited
page 1 of 2Next →

Frequent Co-authors

Þorsteinn Thorsteinsson(8), Ahmed Daak(8), Adrián L. Rabinowicz(8), Miguel A. López‐Toledano(7), Kevin C. Maki(5), Colleen Johns(5), Peter L. Bartner(3), D. BOXLER(3), R. BRAMBILLA(3), Alan K. Mallams(3), Paul Reichert(3), Henry L. Surprenant(3), G. TOMALESKY(3), Ton That Thang(3), Satoshi Ōmura(3), Lydia Valente(2), Alan S. Ryan(2), G. LUKACS(2), J. B. MORTON(2), J. F. BLOUNT(2)